Collagen III (COL3A1) Human shRNA Lentiviral Particle (Locus ID 1281)
CAT#: TL313797V
COL3A1 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.
Need custom lentivirus service?
Get a free quote
CNY 11,400.00
Cited in 2 publications. |
Product images
CNY 2,950.00
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | Collagen III (COL3A1) Human shRNA Lentiviral Particle (Locus ID 1281) |
Locus ID | 1281 |
Synonyms | EDS4A; EDSVASC; PMGEDSV |
Vector | pGFP-C-shLenti |
Format | Lentiviral particles |
RefSeq | NM_000090, NM_000090.1, NM_000090.2, NM_000090.3, BC028178, NM_000090.4 |
Summary | This gene encodes the pro-alpha1 chains of type III collagen, a fibrillar collagen that is found in extensible connective tissues such as skin, lung, uterus, intestine and the vascular system, frequently in association with type I collagen. Mutations in this gene are associated with Ehlers-Danlos syndrome types IV, and with aortic and arterial aneurysms. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
COL3A1 Overexpression Associates with Poor Prognosis and Cisplatin Resistance in Lung Cancer
,null,
Balkan medical journal
,PubMed ID 36148899
[COL3A1]
|
A role for collagen XXIII in cancer cell adhesion, anchorage-independence, and metastasis
,null,
Oncogene
,PubMed ID 21963851
[COL3A1]
|
Documents
Product Manuals |
FAQs |
SDS |